Novacyt S.A. (`Novacyt`, the `Company` or the “Group”): Coronavirus Update
(WorldNews France)

Novacyt S.A. (`Novacyt`, the `Company` or the `Group`): Coronavirus Update 02 Jun 2020 08:00 CEST Company Name NOVACYT ISN FR0010397232 Market Euronext Growth Symbol ALNOV Sales and regulatory update Regulatory News: Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, provides an update on its polymerase chain reaction (PCR) test for COVID-19, developed by Primerdesign, the Company`s molecular diagnostics division. Sales As of 1 June 2020, sales of the Primerdesign COVID-19 test are €45 million (£40 million). In addition, Primerdesign has received orders for, or been contracted to deliver, a further €90 million (£80 million) of its COVID-19 test....